-
Cardio-Oncology Services Growing in Number and Demand
drugs
May 06, 2019
Cardio-Oncology Services Growing in Number and Demand...
-
Does Hormone Therapy for Prostate Cancer Raise Dementia Risk?
drugs
May 06, 2019
Does Hormone Therapy for Prostate Cancer Raise Dementia Risk?
-
Antimalarial drugs could support existing cancer treatments
europeanpharmaceuticalreview
May 05, 2019
Chloroquine and hydroxychloroquine could make cancer treatments more effective…
-
PAC-1-temozolomide combination shows promise for anaplastic astrocytoma
europeanpharmaceuticalreview
May 05, 2019
A drug that spurs cancer cells to self-destruct has been cleared for use in a clinical trial of patients with anaplastic astrocytoma…
-
Comprehensive tumor profiling promises new therapeutic options for patients with advanced cancer
worldpharmanews
May 05, 2019
Comprehensive tumor profiling promises new therapeutic options for patients with advanced cancer.
-
Cabozantinib shows promise as first line treatment for differentiated thyroid cancer
europeanpharmaceuticalreview
May 05, 2019
A kinase inhibitor called cabozantinib could be a viable therapy option for patients with metastatic, radioactive iodine-resistant thyroid cancer…
-
Novel colorectal cancer vaccine shows positive phase I results
europeanpharmaceuticalreview
May 05, 2019
A new vaccine for colorectal cancer has proven to be safe in a small sample of human subjects, opening the way for the next phase of testing.
-
Amgen ignites a social fitness movement to support the fight against heart disease and cancer
worldpharmanews
May 05, 2019
Amgen ignites a social fitness movement to support the fight against heart disease and cancer.
-
Kisqali receives breakthrough therapy designation for advanced breast cancer
europeanpharmaceuticalreview
April 30, 2019
Kisqali receives breakthrough therapy designation for initial endocrine-based treatment of pre- or perimenopausal women with HR+/HER2- advanced or metastatic breast cancer…
-
Cardiff Met develops new cancer treatment
europeanpharmaceuticalreview
April 30, 2019
Cardiff Metropolitan University has been instrumental in the development of a new anti-cancer agent that has the potential to offer a valuable treatment option for cancer…